Jay Turpen BS

Jay has been in the Pharmaceutical Industry for the last 29 years in various leadership roles. He has a wealth of experience in GMP, GLP and GCP environments with significant real-life experience in developing numerous new drug candidates. Most recently, he was the Senior Director for Clinical Project Management where he was responsible for the Clinical Development for Alzheimer’s Disease, Autoimmune Diseases, Men’s Health, Pain, and other Neuroscience indications. Jay retired from Eli Lilly & Co. at the end of 2017 and is now providing consulting services.